{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol+Injection&page=11", "query": { "intervention": "Alcohol Injection", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 302, "total_pages": 31, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol+Injection&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Alcohol+Injection&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-02T14:38:01.808Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01378299", "title": "CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypogonadism" ], "interventions": [ { "name": "Testosterone Cypionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "MALE", "summary": "40 Years to 75 Years · Male only" }, "enrollment_count": 105, "start_date": "2011-10-01", "completion_date": "2017-11-07", "has_results": true, "last_update_posted_date": "2019-03-05", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 2, "location_summary": "Albuquerque, New Mexico • Houston, Texas", "locations": [ { "city": "Albuquerque", "state": "New Mexico" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01378299" }, { "nct_id": "NCT04603911", "title": "RCT Comparing ESPB Solutions in Breast Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Liposomal bupivacaine", "type": "DRUG" }, { "name": "Bupivacaine, epinephrine, dexamethasone, and clonidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tufts Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 75, "start_date": "2020-12-04", "completion_date": "2023-04-10", "has_results": false, "last_update_posted_date": "2025-01-10", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04603911" }, { "nct_id": "NCT03001453", "title": "Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Liposomal Bupivacaine", "type": "DRUG" }, { "name": "0.25% Bupivacaine with epinephrine", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "American Hip Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 107, "start_date": "2014-04", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2018-07-26", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 2, "location_summary": "Hinsdale, Illinois • Westmont, Illinois", "locations": [ { "city": "Hinsdale", "state": "Illinois" }, { "city": "Westmont", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03001453" }, { "nct_id": "NCT03852628", "title": "Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post Traumatic Stress Disorder", "Alcohol Abuse" ], "interventions": [ { "name": "2mg Buprenex and 380mg Vivitrol", "type": "DRUG" }, { "name": "Placebo (SL pill qd, IM injection q4weeks)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pharmacotherapies for Alcohol and Substance Use Disorders Alliance", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 69, "start_date": "2019-05-20", "completion_date": "2023-01-30", "has_results": true, "last_update_posted_date": "2023-09-14", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 2, "location_summary": "Tuscaloosa, Alabama • West Haven, Connecticut", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03852628" }, { "nct_id": "NCT03887650", "title": "LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Post-operative Pain", "Total Shoulder Arthroplasty", "Osteoarthritis of the Shoulder", "Pain Management" ], "interventions": [ { "name": "Liposomal Bupivicaine 1.3%", "type": "DRUG" }, { "name": "Bupivacaine 0.5%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hartford Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 90, "start_date": "2019-03-11", "completion_date": "2022-03-08", "has_results": true, "last_update_posted_date": "2023-09-15", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 1, "location_summary": "Hartford, Connecticut", "locations": [ { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03887650" }, { "nct_id": "NCT06994338", "title": "Tirzepatide for Alcohol Use Disorder", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol Use Disorder", "Obesity and Overweight", "Alcohol" ], "interventions": [ { "name": "Tirzepatide", "type": "DRUG" }, { "name": "Placebo injections", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 42, "start_date": "2025-10-06", "completion_date": "2026-08-31", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06994338" }, { "nct_id": "NCT06120140", "title": "Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Amivantamab IV", "type": "DRUG" }, { "name": "Amivantamab SC", "type": "DRUG" }, { "name": "Lazertinib", "type": "DRUG" }, { "name": "Doxycycline", "type": "DRUG" }, { "name": "Minocycline", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Chlorhexidine", "type": "DRUG" }, { "name": "Noncomedogenic skin moisturizer", "type": "OTHER" }, { "name": "Ruxolitinib", "type": "OTHER" }, { "name": "Tacrolimus", "type": "OTHER" }, { "name": "Zinc gluconate", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Timolol", "type": "DRUG" }, { "name": "Clobetasol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 305, "start_date": "2024-02-16", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 28, "location_summary": "Chandler, Arizona • Duarte, California • Fullerton, California + 25 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06120140" }, { "nct_id": "NCT04207840", "title": "Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pharmacokinetics", "Epinephrine", "Albuterol", "Asthma", "Anaphylaxis" ], "interventions": [ { "name": "Epinephrine (0.125 mg/inhalation)", "type": "COMBINATION_PRODUCT" }, { "name": "Epinephrine Injection Auto-Injector (0.3mg/0.3mL)", "type": "COMBINATION_PRODUCT" }, { "name": "Albuterol Sulfate (0.09 mg/inhalation)", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 28, "start_date": "2019-12-09", "completion_date": "2019-12-23", "has_results": true, "last_update_posted_date": "2021-03-30", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04207840" }, { "nct_id": "NCT07392580", "title": "Intralesional Chemotherapy (IC): Cisplatin + Epinephrine", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Laryngeal Squamous Cell Carcinoma" ], "interventions": [ { "name": "Cisplatin", "type": "DRUG" }, { "name": "Epinephrine injection", "type": "DRUG" }, { "name": "Laryngeal Biopsy", "type": "PROCEDURE" }, { "name": "Endoscopic Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2026-12-01", "completion_date": "2031-09-01", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07392580" }, { "nct_id": "NCT03913845", "title": "The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Stress Urinary Incontinence" ], "interventions": [ { "name": "lidocaine with epinephrine", "type": "DRUG" }, { "name": "Normal saline with epinephrine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "West Penn Allegheny Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "FEMALE", "summary": "18 Years to 99 Years · Female only" }, "enrollment_count": 150, "start_date": "2019-11-25", "completion_date": "2024-11-14", "has_results": true, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-11-02T14:38:01.808Z", "location_count": 4, "location_summary": "Bethel Park, Pennsylvania • Jefferson Hills, Pennsylvania • Pittsburgh, Pennsylvania + 1 more", "locations": [ { "city": "Bethel Park", "state": "Pennsylvania" }, { "city": "Jefferson Hills", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Wexford", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03913845" } ] }